7 results
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Pathophys #Management #EM ... #IM #PCC #Catecholamine ... #Comparison #Table ... Phenylephrine #Dopamine #RebelEM
Event Rates of the Primary End Point and Its Components at 30 Days #EBM #Cardiology #CULPRIT-SHOCK
Components at 30 Days #EBM ... #Cardiology #CULPRIT-SHOCK ... #CULPRITSHOCK #PCI ... #CulpritOnly #shock ... #cardiogenic #NEJM
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock - Event Rates of the
PCI Strategies in ... #EBM #Cardiology ... #CULPRITSHOCK #PCI ... #CulpritOnly #shock ... #cardiogenic #NEJM
Algorithm and Causes of an Elevated Hemidiaphragm #Diagnosis #Radiology #EM #IM #PCC #Elevated #Hemidiaphragm #ElevatedHemidiaphragm #Diaphragm
Hemidiaphragm #Diagnosis ... #Radiology #EM ... #IM #PCC #Elevated
Original and Simplified PESI PulmonaryEmbolism #Diagnosis #EM #IM #PCC #PESI #sPESI #risk #score #PE #Table
PulmonaryEmbolism #Diagnosis ... #EM #IM #PCC #PESI ... risk #score #PE #Table
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
Dabigatran after PCI ... Fibrillation (RE-DUAL PCI ... warfarin (Panel A) #EBM ... #Cardiology #IM ... TripleTherapy #PCI
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... Agents via AHA/ACC ... Management #Pharm #EM ... #IM #Cardiology ... #Afib #Common #